Detail akcie Utah Med Prod online

Business Summary: Utah Medical Products, Inc. is engaged in the business of producing medical services. The Company markets a range of medical devices used in critical care areas, especially the neonatal intensive care unit (NICU), the labor and delivery (L&D) department and the women’s health center in hospitals, as well as medical devices sold to outpatient clinics and physician's offices. The Company’s products include BT-CATH, CVX-RIPE, CVX-RIPE, MUC-X, AROM-CO, DISPOSA-HOOD, DELTRAN PLUS, EPITOME and OptiMicro Electrosurgical Devices, Filshie Clip System, PATHFINDER PLUS, SUPRAPUBIC CATHETERIZATION, LIBERTY System, ENDOCURETTE, and LUMIN. BT-CATH is a uterine balloon tamponade catheter for controlling severe postpartum hemorrhage. MUC-X is an aspiration device used immediately after birth to clear neonatal respiratory passages and reduce exposure to potential infections. AROM-CO is a finger cover with a prong designed to rupture maternal membranes with less patient pain and anxiety.
Financial Summary: BRIEF: For the fiscal year ended 31 December 2023, Utah Medical Products, Inc. revenues decreased 4% to $50.2M. Net income increased 1% to $16.6M. Revenues reflect Blood Pressure Monitoring and Accessories segment decrease of 10% to $16.5M, Neonatal segment decrease of 9% to $6.9M, United States segment decrease of 12% to $30.4M. Net Income benefited from Dividends/Interest increase from $661K to $3M (income).